Yasmin Abaza
- Hematology top 5%
- Acute Myeloid Leukemia Research 45
- Chronic Myeloid Leukemia Treatments 13
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 14
- Chronic Lymphocytic Leukemia Research 6
-
- Histone Deacetylase Inhibitors Research 8
- Protein Degradation and Inhibitors 6
-
- Eosinophilic Disorders and Syndromes 5
-
- Neutropenia and Cancer Infections 4
- Co-authors
- Amer M. ZeidanGuillermo Garcia‐ManeroElias JabbourJacqueline S. GarciaChristine M. McMahonEhab AtallahRobert E. RosesAhmed O. Kaseb
- Cited by
- HematologyGeneticsImmunology
- Journals
- Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (2 papers)Blood (20 papers)
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Yasmin Abaza
50 papers receiving 387 citations
Peers
Comparison fields: 5 of 47
- Hematology 261
- Genetics 87
- Immunology 60
- Molecular Biology 174
- Cancer Research 37
Countries citing papers authored by Yasmin Abaza
This map shows the geographic impact of Yasmin Abaza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasmin Abaza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasmin Abaza more than expected).
Fields of papers citing papers by Yasmin Abaza
This network shows the impact of papers produced by Yasmin Abaza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasmin Abaza. The network helps show where Yasmin Abaza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yasmin Abaza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 29 | |
| 13 | 2022 | 5 | |
| 14 | 2020 | 31 | |
| 15 | 2018 | 8 | |
| 16 | 2017 | 2 | |
| 17 | 2016 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2014 | 3 | |
| 20 | 2012 | 15 |
About Yasmin Abaza
Yasmin Abaza is a scholar working on Hematology, Genetics and Rheumatology, having authored 54 papers that have together received 391 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (45 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (13 papers), Histone Deacetylase Inhibitors Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Protein Degradation and Inhibitors (6 papers), Eosinophilic Disorders and Syndromes (5 papers) and Neutropenia and Cancer Infections (4 papers). The work is most often cited by research in Hematology (261 citations), Genetics (87 citations) and Immunology (60 citations). Yasmin Abaza has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Amer M. Zeidan, Guillermo Garcia‐Manero, Elias Jabbour, Jacqueline S. Garcia, Christine M. McMahon, Ehab Atallah, Robert E. Roses, Ahmed O. Kaseb, Gautam Borthakur and Srđan Verstovšek. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.